The U.S. Army is approaching a significant benchmark in its effort to confront one of modern warfare's most difficult health challenges: the cumulative neurological effects of blast exposure. According to the service's top leader responsible for safety and occupational health, about 97% of soldiers have used the Neurocognitive Assessment Tool, a screening system designed to help medical professionals identify possible brain-health concerns linked to blast overpressure and repeated low-level blast exposure.
The figure represents more than a compliance statistic. It suggests that the Army has moved a large portion of its force into a standardized brain-health monitoring framework at a time when military medicine is still working to understand the long-term consequences of exposure to explosions, training detonations, breaching charges, artillery fire, and other high-energy events. For commanders, medics, and researchers, the near-universal use of the tool offers a broader dataset than ever before on how soldiers respond to these hazards across training and operational environments.
Screening Becomes Routine
The Army's progress reflects a wider institutional shift: neurological monitoring is increasingly being treated as a routine element of force protection rather than an exceptional response after injury. That change matters because blast-related harm is often subtle, cumulative, and difficult to diagnose. Unlike a visible wound, the effects of repeated low-level exposure may emerge gradually through headaches, memory problems, concentration difficulties, sleep disruption, or other symptoms that can be overlooked in fast-moving operational settings.
By pushing the Neurocognitive Assessment Tool across the force, the Army is trying to create a baseline for comparison over time. In practical terms, that means medical professionals can better distinguish between a soldier's normal cognitive profile and changes that may warrant follow-up. The tool also helps the service gather population-level data, which is essential for spotting patterns that might otherwise remain hidden in isolated case reports.
The 97% usage rate is especially notable because it suggests broad acceptance within a large and operationally diverse force. Achieving that level of participation in a military environment is not trivial. It requires sustained command emphasis, administrative coordination, and trust from soldiers who may not always view screening as urgent unless symptoms are obvious. The Army's ability to reach that threshold indicates that brain health has become a visible priority inside the institution.
Blast Exposure Under Watch
The Army's focus on blast overpressure and low-level blast exposure reflects a growing body of concern across the defense and medical communities. Overpressure from explosions can affect the brain even when there is no external injury, while repeated exposure to smaller blasts may produce cumulative effects that are harder to trace. The challenge for military health systems is that the science is still evolving, and the line between temporary symptoms and longer-term neurological risk is not always clear.
That uncertainty has pushed the Army toward a more preventive posture. Rather than waiting for severe symptoms to appear, the service is using screening tools to identify possible issues earlier and to guide medical evaluation. This approach is consistent with broader efforts across the U.S. military to improve readiness by reducing preventable injury and preserving cognitive performance, which is critical for decision-making, situational awareness, and mission execution.
The milestone also carries implications for training and occupational safety. If the Army can better map when and where blast exposure occurs, it may be able to refine protective measures, adjust training practices, and improve monitoring for units that face repeated exposure. That could eventually influence everything from range procedures to equipment design and medical follow-up protocols.
Data For Readiness
The broader significance of the 97% figure lies in what it enables next. Large-scale screening is only the first step. The real value comes from using the data to improve diagnosis, shape policy, and strengthen long-term care for service members. In a force as large as the Army, even small improvements in detection can have outsized effects on readiness, retention, and quality of life.
The Army's emphasis on brain health also reflects a changing understanding of combat injury. For decades, military medicine focused heavily on visible trauma and acute battlefield wounds. Today, the services are increasingly confronting injuries that are less obvious but potentially just as consequential over time. Cognitive health has become a strategic issue, not merely a clinical one.
The near-completion of Neurocognitive Assessment Tool use does not by itself solve the problem of blast-related brain injury. But it does show that the Army has built a foundation for more systematic monitoring at scale. For a force that depends on sharp judgment under pressure, that may prove to be one of the most important readiness investments of all.